According to an independent study, apps will be worth $17.5bn in 2012, compared to only $13.83bn in CD sales. But what does this mean market saturation or an increasing appetite for ever more varied apps? And where does pharma sit in this rapidly moving technology?
Healthy Conversations
Compelling conversations in healthcare communications
